Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-25-000201

Director acquired 3,167 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KANTOFF AARON · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-28 Exercise or conversion : show line 1 in the form +3,167 3,167 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-28 Exercise or conversion : show line 2 in the form Restricted Stock Units −3,167 6,333 D
Loading xslF345X05/primary_doc.xml…